BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15893014)

  • 1. Biological features of bronchial squamous dysplasia followed up by autofluorescence bronchoscopy [Hoshino H, et al. Lung Cancer 2004;46(2):187-96].
    Feoli F; Meert AP
    Lung Cancer; 2005 Jun; 48(3):435-6; author reply 237-8. PubMed ID: 15893014
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological features of bronchial squamous dysplasia followed up by autofluorescence bronchoscopy.
    Hoshino H; Shibuya K; Chiyo M; Iyoda A; Yoshida S; Sekine Y; Iizasa T; Saitoh Y; Baba M; Hiroshima K; Ohwada H; Fujisawa T
    Lung Cancer; 2004 Nov; 46(2):187-96. PubMed ID: 15474667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent loss of E-cadherin and/or catenins in intrabronchial lesions during carcinogenesis of the bronchial epithelium.
    Kato Y; Hirano T; Yoshida K; Yashima K; Akimoto S; Tsuji K; Ohira T; Tsuboi M; Ikeda N; Ebihara Y; Kato H
    Lung Cancer; 2005 Jun; 48(3):323-30. PubMed ID: 15893000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early diagnosis of lung cancer: impact of autofluorescence bronchoscopy].
    Escarguel B; D'Amore D; Chapel F; Bec J; Audigier-Valette C; Lahlah H; Milhe F; Marqueste L
    Rev Pneumol Clin; 2009 Oct; 65(5):287-91. PubMed ID: 19878802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer.
    Merrick DT; Kittelson J; Winterhalder R; Kotantoulas G; Ingeberg S; Keith RL; Kennedy TC; Miller YE; Franklin WA; Hirsch FR
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2281-8. PubMed ID: 16609045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High incidence of chromosomal abnormalities at 1p36 and 9p21 in early-stage central type squamous cell carcinoma and squamous dysplasia of bronchus detected by autofluorescence bronchoscopy.
    Shibukawa K; Miyokawa N; Tokusashi Y; Sasaki T; Osanai S; Ohsaki Y
    Oncol Rep; 2009 Jul; 22(1):81-7. PubMed ID: 19513508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung.
    Larsen JE; Colosimo ML; Yang IA; Bowman R; Zimmerman PV; Fong KM
    Carcinogenesis; 2006 Mar; 27(3):525-32. PubMed ID: 16195240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas.
    Ishikawa N; Takano A; Yasui W; Inai K; Nishimura H; Ito H; Miyagi Y; Nakayama H; Fujita M; Hosokawa M; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
    Cancer Res; 2007 Dec; 67(24):11601-11. PubMed ID: 18089789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGA2 overexpression in non-small cell lung cancer.
    Meyer B; Loeschke S; Schultze A; Weigel T; Sandkamp M; Goldmann T; Vollmer E; Bullerdiek J
    Mol Carcinog; 2007 Jul; 46(7):503-11. PubMed ID: 17477356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter methylation of genes in bronchial lavages: a marker for early diagnosis of primary and relapsing non-small cell lung cancer?
    de Fraipont F; Moro-Sibilot D; Michelland S; Brambilla E; Brambilla C; Favrot MC
    Lung Cancer; 2005 Nov; 50(2):199-209. PubMed ID: 16043258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Ki67 a marker for the transformation of laryngeal dysplasia to carcinoma?
    Mirza S; Jeannon JP; Soames J; Wilson JA
    Acta Otolaryngol; 2006 Apr; 126(4):418-21. PubMed ID: 16608796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gain of 1q25-32, 12q23-24.3, and 17q12-22 facilitates tumorigenesis and progression of human squamous cell lung cancer.
    Ma J; Gao M; Lu Y; Feng X; Zhang J; Lin D; Xiao T; Hu Z; Yuan J; Su K; Shipley J; Xue J; Gao Y
    J Pathol; 2006 Oct; 210(2):205-13. PubMed ID: 16927450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic bronchoscopy interventions before surgical resection of lung cancer.
    Chhajed PN; Eberhardt R; Dienemann H; Azzola A; Brutsche MH; Tamm M; Herth FJ
    Ann Thorac Surg; 2006 May; 81(5):1839-43. PubMed ID: 16631682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular predictors of chemotherapy response in non-small-cell lung cancer.
    Gray J; Simon G; Bepler G
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):545-9. PubMed ID: 17428174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual digital video-autofluorescence imaging for detection of pre-neoplastic lesions.
    Lee P; Brokx HA; Postmus PE; Sutedja TG
    Lung Cancer; 2007 Oct; 58(1):44-9. PubMed ID: 17532537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIK3CA gene amplification in Japanese non-small cell lung cancer.
    Kawano O; Sasaki H; Okuda K; Yukiue H; Yokoyama T; Yano M; Fujii Y
    Lung Cancer; 2007 Oct; 58(1):159-60. PubMed ID: 17681398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
    Woenckhaus M; Klein-Hitpass L; Grepmeier U; Merk J; Pfeifer M; Wild P; Bettstetter M; Wuensch P; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
    J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant methylation of H-cadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinoma.
    Kim JS; Han J; Shim YM; Park J; Kim DH
    Cancer; 2005 Nov; 104(9):1825-33. PubMed ID: 16177988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.
    Woenckhaus M; Merk J; Stoehr R; Schaeper F; Gaumann A; Wiebe K; Hartmann A; Hofstaedter F; Dietmaier W
    Hum Pathol; 2008 Jan; 39(1):126-36. PubMed ID: 17949785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.